Stephen Rapp to Methylphenidate
This is a "connection" page, showing publications Stephen Rapp has written about Methylphenidate.
Connection Strength
0.152
-
Gleason JF, Case D, Rapp SR, Ip E, Naughton M, Butler JM, McMullen K, Stieber V, Saconn P, Shaw EG. Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol. 2007 Oct; 5(9):427-33, 436.
Score: 0.076
-
Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1496-501.
Score: 0.076